Haemonetics Q2 2026 Results: Net Income $46.3M, Up 19.7% YoY
Haemonetics Corp reported net revenues of $357.8 million for the quarter ended September 26, 2026, a 9.3% increase compared to the prior year. Net income rose to $46.3 million, driven by higher gross profits and the absence of intangible asset impairments that occurred in the previous year's quarter.
- Key figure
- Net income $46.3M · +19.7% YoY